Skip to main content
. 2020 Nov 5;25(21):5158. doi: 10.3390/molecules25215158

Figure 4.

Figure 4

Plasma concentrations of oxidatively modified tyrosine in colorectal cancer patients during early postoperative period: (a) 3-Nitro-l-tyrosine (3-NT); (b) 3-Chloro-l-tyrosine (3-CT); (c) 3-Bromo-l-tyrosine (3-BT).